Medicine & Health

Researchers at Washington University School of Medicine have received $8 million from the National Institutes of Health (NIH) for two school-based projects — one in St. Louis County and the other in Maryland — aimed at safely returning students and staff to in-person school.

A team led by researchers at the School of Medicine has identified, in mice, specific cells and proteins that control the sneeze reflex. Better understanding of what causes sneezing may point to treatments to slow the spread of infectious respiratory diseases.

Jai Rudra, assistant professor at the McKelvey School of Engineering, will use a CAREER Award from the National Science Foundation to study chirality in nanomaterials and ultimately help design safer synthetic nanomaterial vaccines.

Researchers at Washington University School of Medicine have identified the brain regions involved in choosing whether to find out if a bad event is about to happen. The findings are published June 11 in Neuron.

Faculty from the McKelvey School of Engineering and the School of Medicine teamed up to design better grafts for dialysis patients.

A new study led by Washington University School of Medicine provides new guidance on the treatment of medulloblastoma, a pediatric brain cancer. Some aspects of radiation therapy may be reduced while still providing effective treatment.

Researchers at the School of Medicine and the University of Chicago have found that a single, one-hour treatment that involves breathing in laughing gas can significantly improve symptoms in people with treatment-resistant depression.

Six winners have been selected for the 2021-22 Big Ideas Competition award. The competition identifies and supports high-priority, novel projects from collaborative teams developing innovations in informatics and health-care delivery.

New School of Medicine research shows that international travelers often return home with new bacterial strains jostling for position within the gut microbiome. Such travel is contributing to the rapid global increase and spread of antimicrobial resistance.

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.